The “Fmoc” group is a protecting group used in solid-phase peptide synthesis to manage the reaction, while the lengthy “C20-OtBu-L-Glu(OtBu)-AA-AA” side chain is essential for creating the final, complex peptide structure. Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is a specialized chemical intermediate employed to synthesize therapeutic peptides, most notably Tirzepatide, a dual GIP and GLP-1 receptor agonist for type 2 diabetes and weight loss.
Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH
| API Name | Tirzepatide |
|---|---|
| CAS No | 2915356-76-0 |
| Molecular Formula | C66H105N5O16 |
| Molecular Weight | 1224.6 g/mol |
| Synonyms | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosa -Show More |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
The "Fmoc" group is a protecting group used in solid-phase peptide synthesis to manage the reaction, while the lengthy "C20-OtBu-L-Glu(OtBu)-AA-AA" side chain is essential for creating the final, complex peptide structure. Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is a specialized chemical intermediate employed to synthesize therapeutic peptides, most notably Tirzepatide, a dual GIP and GLP-1 receptor agonist for type 2 diabetes and weight loss.
The CAS number of Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is 2915356-76-0.
The molecular formula of Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is C66H105N5O16.
The listed molecular weight of Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is 1224.6 g/mol.
Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is listed as being used in connection with the following API: Tirzepatide.
The listed synonym or IUPAC name for Fmoc-L-Lys(C20-OtBu-L-Glu(OtBu)-AA-AA)-OH is (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosa -Show More.